Abeona Therapeutics Inc (ABEO)
4.45
+0.05
(+1.14%)
USD |
NASDAQ |
May 09, 16:00
4.46
+0.01
(+0.22%)
After-Hours: 20:00
Abeona Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -475.8% |
| March 31, 2023 | |
| December 31, 2022 | -10.47K% |
| September 30, 2022 | |
| June 30, 2022 | -409.7% |
| March 31, 2022 | -6.37K% |
| December 31, 2021 | -1.56K% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -527.6% |
| September 30, 2020 | -103.4% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -3.63K% |
| September 30, 2018 | -960.7% |
| June 30, 2018 | -4.44K% |
| March 31, 2018 | -1.98K% |
| December 31, 2017 | -3.93K% |
| September 30, 2017 | -2.44K% |
| June 30, 2017 | -3.82K% |
| Date | Value |
|---|---|
| March 31, 2017 | -2.82K% |
| December 31, 2016 | -2.74K% |
| September 30, 2016 | -1.43K% |
| June 30, 2016 | -3.13K% |
| March 31, 2016 | -2.36K% |
| December 31, 2015 | -1.09K% |
| September 30, 2015 | -2.13K% |
| June 30, 2015 | -1.46K% |
| March 31, 2015 | -775.2% |
| December 31, 2014 | -5.10K% |
| September 30, 2014 | -622.5% |
| June 30, 2014 | -5.06K% |
| March 31, 2014 | -413.0% |
| December 31, 2013 | -663.6% |
| September 30, 2013 | -83.07% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -1.71K% |
| June 30, 2012 | -1.54K% |
| March 31, 2012 | -266.3% |
| December 31, 2011 | 56.43% |
| September 30, 2011 | 33.62% |
| June 30, 2011 | -842.7% |
| March 31, 2011 | -1.27K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.47K%
Minimum
Dec 2022
-103.4%
Maximum
Sep 2020
-2.85K%
Average
-527.6%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| T2 Biosystems Inc | -615.8% |
| INVO Bioscience Inc | -144.4% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.23% |
| Xtant Medical Holdings Inc | -15.31% |